KN
Kedar Nath Senapati
About Kedar Nath Senapati
Data last updated:
Kedar Nath Senapati is a Director at Softdeal Pharmaceutical Private Limited (since 2022), Director at Neetnav Real Estate Private Limited (since 2025) and Director at Caraco Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹235 Cr; the largest is Softdeal Pharmaceutical Private Limited at ₹235 Cr (FY 2025). Earlier, Kedar Nath Senapati was a Whole-Time Director at Skisen Labs Private Limited (from 2024) and Director at Green Eco Development Centre Limited (from 2021) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Softdeal Pharmaceutical Private Limited U51900MH2006PTC159237 | Director | 21 Feb 2022 | 2006 | ₹235 Cr (FY 2025) | Active |
| Neetnav Real Estate Private Limited U45200MH2010PTC201611 | Director | 29 Jul 2025 | 2010 | ₹19.2 Lakh (FY 2025) | Active |
| Caraco Pharmaceuticals Private Limited U24100MH2012FTC225970 | Director | 29 Jul 2025 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Skisen Labs Private Limited U73100GJ2005PTC133239 | Whole-Time Director | 29 Jan 2024 | 2005 | Amalgamated | |
| Green Eco Development Centre Limited U90009GJ2010PLC062892 | Director | 13 Oct 2021 | 2010 | ₹16,000 (FY 2023) | Amalgamated |
| Pinewood Diagnostics Limited U85195DL1998PLC095877 | Additional Director | 20 Feb 2025 | 1998 | Strike Off | |
 Sun Pharmaceutical Medicare Limited U36900GJ2017PLC095132 | Director | 29 Jan 2024 | 2017 | ₹419 Cr (FY 2025) | Amalgamated |
| Realstone Multitrade Private Limited U51900GJ2006PTC133238 | Director | 29 Jan 2024 | 2006 | ₹74,348 (FY 2022) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kedar Nath Senapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prince Kalarickal Elias | 07292533 | Softdeal Pharmaceutical Private Limited , Neetnav Real Estate Private Limited and 1 more | Director |
| Rakeshchandra Jagdishprasad Sinha | 07340998 | Softdeal Pharmaceutical Private Limited , Neetnav Real Estate Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kedar Nath Senapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kedar Nath Senapati
Kedar Nath Senapati currently holds 3 directorships: Softdeal Pharmaceutical Private Limited (Director, since 21 Feb 2022, revenue ₹235 Cr (FY 2025)); Neetnav Real Estate Private Limited (Director, since 29 Jul 2025, revenue ₹19.2 Lakh (FY 2025)); Caraco Pharmaceuticals Private Limited (Director, since 29 Jul 2025).
Kedar Nath Senapati was first appointed on 13 Oct 2021 as Director at Green Eco Development Centre Limited. The most recent appointment on record is 29 Jul 2025 at Caraco Pharmaceuticals Private Limited.
The 2 current companies of Kedar Nath Senapati that report revenue have a combined latest revenue of ₹235 Cr: Softdeal Pharmaceutical Private Limited ₹235 Cr (FY 2025); Neetnav Real Estate Private Limited ₹19.2 Lakh (FY 2025).
Kedar Nath Senapati held 5 earlier board appointments: Skisen Labs Private Limited (Whole-Time Director, from 29 Jan 2024); Green Eco Development Centre Limited (Director, from 13 Oct 2021); Pinewood Diagnostics Limited (Additional Director, from 20 Feb 2025); Sun Pharmaceutical Medicare Limited (Director, from 29 Jan 2024); Realstone Multitrade Private Limited (Director, from 29 Jan 2024).
The current boards of Kedar Nath Senapati's companies include Prince Kalarickal Elias (Softdeal Pharmaceutical Private Limited), Rakeshchandra Jagdishprasad Sinha (Softdeal Pharmaceutical Private Limited).